Advanced company searchLink opens in new window

AKARI THERAPEUTICS, PLC

Company number 05252842

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
16 May 2024 TM01 Termination of appointment of Rachelle Suzanne Jacques as a director on 7 May 2024
14 May 2024 SH01 Statement of capital following an allotment of shares on 28 March 2024
  • USD 1,584,739.1523
14 May 2024 SH01 Statement of capital following an allotment of shares on 29 December 2023
  • USD 1,320,616.3523
14 May 2024 SH01 Statement of capital following an allotment of shares on 9 November 2023
  • USD 1,131,042.7523
30 Apr 2024 AP01 Appointment of Mr Samir Rashmikant Patel as a director on 29 November 2023
29 Apr 2024 CH01 Director's details changed for Mr Donald Allen Williams on 18 August 2023
29 Apr 2024 CH01 Director's details changed for Ms Rachelle Suzanne Jacques on 18 August 2023
29 Apr 2024 CH01 Director's details changed for Mr Mohamed Wa’El Ahmed Hashad on 18 August 2023
29 Apr 2024 CH01 Director's details changed for Michael Grissinger on 18 August 2023
02 Nov 2023 SH01 Statement of capital following an allotment of shares on 11 October 2023
  • USD 1,130,595.3523
27 Oct 2023 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
25 Oct 2023 MA Memorandum and Articles of Association
16 Oct 2023 CS01 Confirmation statement made on 7 October 2023 with no updates
06 Oct 2023 CH01 Director's details changed for Mr Donald Allen Williams on 1 January 2023
07 Aug 2023 SH01 Statement of capital following an allotment of shares on 30 June 2023
  • USD 1,012,232.1523
17 Jul 2023 MA Memorandum and Articles of Association
17 Jul 2023 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of alteration of Articles of Association
06 Jul 2023 AP01 Appointment of Mr Mohamed Wa’El Ahmed Hashad as a director on 30 June 2023
04 Jul 2023 TM01 Termination of appointment of Stuart Charles Ungar as a director on 30 June 2023
04 Jul 2023 TM01 Termination of appointment of James Ferguson Hill as a director on 30 June 2023
04 Jul 2023 TM01 Termination of appointment of David Anthony Byrne as a director on 30 June 2023
17 Jun 2023 AA Group of companies' accounts made up to 31 December 2022
18 Apr 2023 SH01 Statement of capital following an allotment of shares on 31 March 2023
  • USD 1,011,158.3823
04 Jan 2023 SH01 Statement of capital following an allotment of shares on 16 September 2022
  • USD 744,491.7123
13 Oct 2022 CS01 Confirmation statement made on 7 October 2022 with no updates